Delivery Order SPE2DB20D3101-SPE2DB24FRAJ4
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, including the drug Livalo 1 mg tablet. The contract has a ceiling value of $1,351.28 and runs through February 7, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,252.93 Firm Fixed Price Delivery Order covers the provision of LIVALO 1 MG TAB 90S, a pharmaceutical product. The contract has an ultimate completion date of January 13, 2025 and was awarded on December 13, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,114.51 firm fixed-price delivery order is for the supply of LIVALO 1 MG TABLET 90S, a prescription medication. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This single-award IDC serves as the primary...
- This firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the medication Livalo 1 mg tablets. The $1,954.82 contract has a completion date of November 27, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This federal contract award, with an ID of SPE2DB20D3103|SPE2DB24FL6R2, was issued by the Defense Logistics Agency (DLA) to the prime contractor, AmerisourceBergen Drug Corp, for the delivery of 4562909046 LIVALO 1 MG TABLET 90S. The contract has a firm fixed price of $2,226.56 and a completion date of November 28, 2023. The contract is a delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Livalo 4 mg tablets (90-count) with a ceiling value of $2,527.91 under a firm fixed-price contract type. The award was issued on December 29, 2025, with an ultimate completion date of December 30, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its Corporate Office location. This...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver a range of pharmaceutical products and medical supplies to the U.S. government. The $25,547.09 Firm Fixed Price contract is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of January 16, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $235,150.92 for the supply of pharmaceutical and medical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a period of performance through January 2, 2024 and is a firm fixed-price arrangement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,260.00 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has an ultimate completion date of May 8, 2025, is not set aside and allows for the supply of a variety of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of LIVALO 4 MG TABLET 90S, a prescription medication. The contract has a firm-fixed price pricing type, a ceiling value of $1,894.44, and a period of performance ending on September 17, 2024. The contract was awarded on September 16, 2024 and was not set aside for any special program. As a large pharmaceutical...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FRAJ4Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was made by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,025.93 firm fixed-price delivery order is for the pharmaceutical product Livalo 2 mg tablet, with a completion date of February 1, 2024. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated with a set-aside. The contract supports the procurement of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care items across multiple therapeutic areas for military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 1/31/24 |